NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution ...
Zenas BioPharma Inc, a clinical-stage global biopharmaceutical company, has announced its management team will present in a fireside chat at the Guggenheim SMID Cap Biotech Conference on Feb 5.